# Therapeutic Goods Administration (TGA)

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/therapeutic-goods-administration-tga
Canonical HTML page: https://gethealthbrief.com/entity/therapeutic-goods-administration-tga

## Timeline

- **2026-02-27**: TGA Approval — Australian regulators approve the Virtual Nodule Clinic for clinical use.
- **2024-02-27**: Public Advocacy Surge — Increased media coverage and patient advocacy highlight the pricing disparity between genders.
- **2022-09-20**: Series A Funding — Company raises $14M to scale global commercial operations.
- **2021-03-15**: FDA Clearance — Optellum receives first-of-its-kind FDA clearance for lung cancer AI.
- **2020-11-15**: TGA Approval — The Therapeutic Goods Administration approves the first female-specific testosterone cream.
- **2019-09-01**: Global Consensus Statement — International medical societies reach consensus on testosterone use for women's sexual health.

## Recent coverage (4 stories)

### Medicinal Cannabis Adoption Surges for PTSD and Sleep Disorders in Australia
2026-03-20 23:02:56 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The public endorsement of medicinal cannabis by patients like Bilal Cassim for PTSD and insomnia highlights a significant shift in Australian healthcare toward cannabinoid therapies. This trend reflects a broader move toward alternative mental health treatments as the clinical and regulatory landscape continues to evolve.
Full story: https://gethealthbrief.com/story/medicinal-cannabis-ptsd-sleep-trends-australia

### Australia Slashes Spinal Implant Subsidies Over Safety and Efficacy Concerns
2026-02-27 09:18:50 · Sentiment: Negative · Impact: 7/10 · Sources: 3

The Australian government is significantly reducing funding for expensive spinal cord stimulators following reports linking the devices to severe patient injuries. This regulatory shift follows a clinical review that found the high-cost implants often provide no long-term benefit over conservative care.
Full story: https://gethealthbrief.com/story/australia-spinal-implant-subsidy-cuts

### Australia's Testosterone Gender Gap: Women Face Higher Costs for Vital Therapy
2026-02-27 02:58:12 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Australian women are facing significant financial barriers to accessing testosterone therapy, often paying substantially more than men for the same hormone treatment. While the therapy is clinically recognized for treating sexual dysfunction in postmenopausal women, the lack of subsidized options highlights a systemic gap in the national pharmaceutical framework.
Full story: https://gethealthbrief.com/story/australia-testosterone-gender-gap-pricing

### Optellum Gains TGA Approval for AI Lung Cancer Diagnostic Tool in Australia
2026-02-27 02:29:49 · Sentiment: Positive · Impact: 7/10 · Sources: 3

Optellum has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for its AI-driven lung nodule management platform. This expansion allows Australian clinicians to utilize advanced imaging analytics to improve early lung cancer detection and streamline patient care pathways.
Full story: https://gethealthbrief.com/story/optellum-tga-approval-australia-lung-cancer-ai

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.